Korea mulls compulsory licensing over Tamiflu

Published: 2009-08-26 07:00:00

Updated: 2009-08-26 07:00:00

The Ministry of Health, Welfare and Family Affairs said that the government is considering taking a compulsory measure that stops the patent periods of antiviral agents, including Tamiflu and allows the domestic production of their generic drugs.

Such an action would be possible when the gove...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK